| Product NDC: | 0555-0635 |
| Proprietary Name: | Danazol |
| Non Proprietary Name: | Danazol |
| Active Ingredient(s): | 200 mg/1 & nbsp; Danazol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0555-0635 |
| Labeler Name: | Barr Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074582 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19960809 |
| Package NDC: | 0555-0635-09 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (0555-0635-09) |
| NDC Code | 0555-0635-09 |
| Proprietary Name | Danazol |
| Package Description | 60 CAPSULE in 1 BOTTLE (0555-0635-09) |
| Product NDC | 0555-0635 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Danazol |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19960809 |
| Marketing Category Name | ANDA |
| Labeler Name | Barr Laboratories Inc. |
| Substance Name | DANAZOL |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] |